Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on January 11, 2012, involving the purchase of Ordinary shares at a price of 1435.17 pence per share through the Company's Share Reward Plan. The transaction involved:
- Director/PDMR: Mr P C Thomson
- Connected Person: Mrs K Thomson
- Acquisition Details: Acquisition of 2 Ordinary shares under the personal contribution element and 2 Ordinary shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total number of shares acquired by the connected person (4 shares total: 2 personal, 2 matched).
- Confirm the transaction price of 1435.17 pence per Ordinary share.
- Note that this filing does not contain financial performance data for the period.